Article Text

Download PDFPDF
Prevalence of an abnormal ankle-brachial index in patients with primary antiphospholipid syndrome: preliminary data
  1. M A Barón,
  2. M A Khamashta,
  3. G R V Hughes,
  4. D P D’Cruz
  1. Lupus Research Unit, The Rayne Institute, St Thomas’ Hospital, London SE1 7EH, UK
  1. Correspondence to:
    Dr D P D’Cruz
    david.d'cruzkcl.ac.uk

Abstract

Objectives: To evaluate the prevalence of abnormal ankle-brachial indexes (ABIs), their relationship with other cardiovascular risk factors and/or the presence of antiphospholipid antibodies (aPL), and the clinical use of the ABI in patients with primary antiphospholipid syndrome (primary APS).

Methods: An 8 MHz Doppler probe was used in the arms and legs to assess the ABI in 43 patients with primary APS (mean (SD) age 40.2 (7.9) years) and 49 healthy subjects (aged 41.0 (11.7)) matched for age and sex. Data on traditional cardiovascular risk factors, such as hypertension, hypercholesterolaemia, presence of diabetes mellitus, nephrotic syndrome or renal failure, smoking, and other variables, were collected at that time for all subjects. A ratio of the highest blood pressure from the posterior tibial or pedal arteries of each leg to the highest blood pressure from the brachial arteries <1.00 was considered abnormal.

Results: Abnormal ABIs were found in 8/43 (19%) patients with primary APS and 2/49 (4%) controls (p = 0.026). No correlation between abnormal ABI and traditional cardiovascular risk factors nor with the presence of aPL was found.

Conclusion: Abnormal ABIs are more common in primary APS than in healthy controls, possibly indicating a subclinical atherosclerotic process in these patients.

  • ABI, ankle-brachial index
  • aCL, anticardiolipin antibodies
  • aPL, antiphospholipid antibodies
  • APS, antiphospholipid syndrome
  • β2GPI, β2-glycoprotein I
  • LA, lupus anticoagulant
  • LDL, low density lipoprotein
  • SLE, systemic lupus erythematosus
  • ankle brachial index
  • accelerated atherosclerosis
  • antiphospholipid antibodies
  • primary antiphospholipid syndrome

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes